NCT06476873

Brief Summary

The main aim of this descriptive cross-sectional study is to assess the prevalence of chemsex substance use disorder among chemsexers via an online self-questionnaire.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 27, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

June 27, 2024

Status Verified

June 1, 2024

Enrollment Period

10 months

First QC Date

June 17, 2024

Last Update Submit

June 21, 2024

Conditions

Addiction ChemicalUse, Substance

Outcome Measures

Primary Outcomes (1)

  • DSM-5 diagnosis of substance use disorder for chemsex.

    Assessment of the prevalence of chemsex substance use disorder among chemsexers via an online self-questionnaire.

    1 day

Secondary Outcomes (4)

  • Describing the sociodemographic characteristics of this population

    1 day

  • Describing the consumption practices of this population

    1 day

  • Describing the sexual practices of this population

    1 day

  • Explore the existence of chemsex use disorder as a clinical entity in its own right

    1 day

Interventions

Online self-questionnaire.BEHAVIORAL

Descriptive, cross-sectional study This study is aimed at adult chemsex users over the last 12 months (having experimented with chemsex at least once over the last 12 months) and with a good understanding of French. An online LimeSurvey-type self-questionnaire will be accessible via a URL link to collect and secure the data. A presentation of the study, information on chemsex and help and care services, as well as the information note will be available. The questionnaire will be distributed via a QR code, giving direct access to the study's web page, or directly via the web link. Posters and flyers will be used in hospitals and/or private clinics, addictology centers, STI prevention and screening centers and associations, as well as via social networks, dating apps and sites, and the online and print press.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be 18 years of age or older.
  • Proficiency in written French
  • Have practised chemsex at least once in the last 12 months.
  • Agree to participate in the study.

You may not qualify if:

  • Have not experimented with chemsex in the last 12 months
  • Participation in other ongoing research
  • Insufficient written comprehension of French

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Charles PERRENS

Bordeaux, 33076, France

Location

Related Publications (5)

  • Diestelmann M, Zangl A, Herrle I, Koch E, Graw M, Paul LD. MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations. Forensic Sci Int. 2018 Feb;283:72-84. doi: 10.1016/j.forsciint.2017.12.003. Epub 2017 Dec 8.

    PMID: 29275216BACKGROUND

  • Blanc JV, Burdairon JD, Malandain L, Ferreri F, Mouchabac S, Adrien V. Attachment and Mental Health of Men Having Sex with Men Engaging in Chemsex: Is Substance Abuse Only the Tip of the Iceberg? J Homosex. 2024 Oct 14;71(12):2875-2894. doi: 10.1080/00918369.2023.2266086. Epub 2023 Oct 10.

    PMID: 37815854BACKGROUND

  • Serre A, Vuillot O, Eiden C, Gambier J, Berger A, Mathieu O, Nefau T, Sebbane M, Donnadieu-Rigole H, Peyriere H. Acute Psychiatric Disorders Related to Fake Cathinone: Ephylone. J Anal Toxicol. 2019 Aug 23;43(7):e1-e2. doi: 10.1093/jat/bkz020. No abstract available.

    PMID: 31095710BACKGROUND

  • Evers YJ, Van Liere GAFS, Hoebe CJPA, Dukers-Muijrers NHTM. Chemsex among men who have sex with men living outside major cities and associations with sexually transmitted infections: A cross-sectional study in the Netherlands. PLoS One. 2019 May 14;14(5):e0216732. doi: 10.1371/journal.pone.0216732. eCollection 2019.

    PMID: 31086390BACKGROUND

  • Gilbart VL, Simms I, Gobin M, Oliver I, Hughes G. High-risk drug practices in men who have sex with men. Lancet. 2013 Apr 20;381(9875):1358-1359. doi: 10.1016/S0140-6736(13)60882-X. No abstract available.

    PMID: 23601946BACKGROUND

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Central Study Contacts

Melina FATSEAS

CONTACT

05 24 54 90 00melina.fatseas@chu-bordeaux.fr

Helen SAVARIEAU

CONTACT

05 56 56 35 56hsavarieau@ch-perrens.fr

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: cohort
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2024

First Posted

June 27, 2024

Study Start

July 1, 2024

Primary Completion

April 30, 2025

Study Completion

August 30, 2025

Last Updated

June 27, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)